Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment

Inclusion Criteria:

• Patients over 18 years of age
• Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
• Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)

Inclusion criteria for the control arm (treated by ACEi):

• Patients over 18 years of age
• Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
• Patients, who tolerate ACEi treatment

Exclusion Criteria:

• Cholestasis, severe hepatic insufficiency
• Allergy to telmisartan
• Gravidity or lactation

Exclusion criteria for the arm of patient treated by ACEi:

• Cholestasis, severe hepatic insufficiency
• Allergy to ACEi
• Gravidity or lactation